Abbott Laboratories (NYSE:ABT) Position Lifted by Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB increased its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 34.6% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 249,000 shares of the healthcare product maker’s stock after buying an additional 64,000 shares during the […]
More Stories
Smithfield Trust Co Has $6.73 Million Position in Alphabet Inc. (NASDAQ:GOOGL)
Smithfield Trust Co raised its position in Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 0.6% in the first quarter, HoldingsChannel.com...
Blair William & Co. IL Acquires 300 Shares of Carpenter Technology Corporation (NYSE:CRS)
Blair William & Co. IL increased its holdings in Carpenter Technology Corporation (NYSE:CRS – Free Report) by 7.9% during the...
Blair William & Co. IL Buys 2,090 Shares of Boot Barn Holdings, Inc. (NYSE:BOOT)
Blair William & Co. IL boosted its stake in Boot Barn Holdings, Inc. (NYSE:BOOT – Free Report) by 52.4% in...
Blair William & Co. IL Boosts Stock Position in MediaAlpha, Inc. (NYSE:MAX)
Blair William & Co. IL lifted its position in MediaAlpha, Inc. (NYSE:MAX – Free Report) by 20.9% during the 1st...
Blair William & Co. IL Boosts Stock Holdings in Cognizant Technology Solutions Corporation (NASDAQ:CTSH)
Blair William & Co. IL raised its holdings in shares of Cognizant Technology Solutions Corporation (NASDAQ:CTSH – Free Report) by...
PTC Therapeutics (NASDAQ:PTCT) Price Target Raised to $79.00 at Wells Fargo & Company
PTC Therapeutics (NASDAQ:PTCT – Free Report) had its price target lifted by Wells Fargo & Company from $78.00 to $79.00...